These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 25762721)

  • 21. Biochemical and behavioral effects of PDE10A inhibitors: Relationship to target site occupancy.
    Li YW; Seager MA; Wojcik T; Heman K; Molski TF; Fernandes A; Langdon S; Pendri A; Gerritz S; Tian Y; Hong Y; Gallagher L; Merritt JR; Zhang C; Westphal R; Zaczek R; Macor JE; Bronson JJ; Lodge NJ
    Neuropharmacology; 2016 Mar; 102():121-35. PubMed ID: 26522433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De Novo Mutations in PDE10A Cause Childhood-Onset Chorea with Bilateral Striatal Lesions.
    Mencacci NE; Kamsteeg EJ; Nakashima K; R'Bibo L; Lynch DS; Balint B; Willemsen MA; Adams ME; Wiethoff S; Suzuki K; Davies CH; Ng J; Meyer E; Veneziano L; Giunti P; Hughes D; Raymond FL; Carecchio M; Zorzi G; Nardocci N; Barzaghi C; Garavaglia B; Salpietro V; Hardy J; Pittman AM; Houlden H; Kurian MA; Kimura H; Vissers LE; Wood NW; Bhatia KP
    Am J Hum Genet; 2016 Apr; 98(4):763-71. PubMed ID: 27058447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphodiesterase 10A (PDE10A) localization in the R6/2 mouse model of Huntington's disease.
    Leuti A; Laurenti D; Giampà C; Montagna E; Dato C; Anzilotti S; Melone MA; Bernardi G; Fusco FR
    Neurobiol Dis; 2013 Apr; 52():104-16. PubMed ID: 23220622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation.
    Threlfell S; Sammut S; Menniti FS; Schmidt CJ; West AR
    J Pharmacol Exp Ther; 2009 Mar; 328(3):785-95. PubMed ID: 19056933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the binding properties of T-773 as a PET radioligand for phosphodiesterase 10A.
    Harada A; Suzuki K; Miura S; Hasui T; Kamiguchi N; Ishii T; Taniguchi T; Kuroita T; Takano A; Stepanov V; Halldin C; Kimura H
    Nucl Med Biol; 2015 Feb; 42(2):146-54. PubMed ID: 25451212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesterase.
    Xie Z; Adamowicz WO; Eldred WD; Jakowski AB; Kleiman RJ; Morton DG; Stephenson DT; Strick CA; Williams RD; Menniti FS
    Neuroscience; 2006 May; 139(2):597-607. PubMed ID: 16483723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CASK phosphorylation by PKA regulates the protein-protein interactions of CASK and expression of the NMDAR2b gene.
    Huang TN; Chang HP; Hsueh YP
    J Neurochem; 2010 Mar; 112(6):1562-73. PubMed ID: 20067577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions.
    Mango D; Bonito-Oliva A; Ledonne A; Nisticò R; Castelli V; Giorgi M; Sancesario G; Fisone G; Berretta N; Mercuri NB
    Neuropharmacology; 2014 Jan; 76 Pt A():127-36. PubMed ID: 23973317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pivotal role of phosphodiesterase 10A in the integration of dopamine signals in mice striatal D
    Mota É; Bompierre S; Betolngar D; Castro LRV; Vincent P
    Br J Pharmacol; 2021 Dec; 178(24):4873-4890. PubMed ID: 34399440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology.
    Giorgi M; Melchiorri G; Nuccetelli V; D'Angelo V; Martorana A; Sorge R; Castelli V; Bernardi G; Sancesario G
    Neurobiol Dis; 2011 Jul; 43(1):293-303. PubMed ID: 21515371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TAK-063, a PDE10A Inhibitor with Balanced Activation of Direct and Indirect Pathways, Provides Potent Antipsychotic-Like Effects in Multiple Paradigms.
    Suzuki K; Harada A; Suzuki H; Miyamoto M; Kimura H
    Neuropsychopharmacology; 2016 Aug; 41(9):2252-62. PubMed ID: 26849714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
    Suvarna NU; O'Donnell JM
    J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model.
    Giralt A; Saavedra A; Carretón O; Arumí H; Tyebji S; Alberch J; Pérez-Navarro E
    Hippocampus; 2013 Aug; 23(8):684-95. PubMed ID: 23576401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pin1 Modulates the Synaptic Content of NMDA Receptors via Prolyl-Isomerization of PSD-95.
    Antonelli R; De Filippo R; Middei S; Stancheva S; Pastore B; Ammassari-Teule M; Barberis A; Cherubini E; Zacchi P
    J Neurosci; 2016 May; 36(20):5437-47. PubMed ID: 27194325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphodiesterase regulation of alcohol drinking in rodents.
    Logrip ML
    Alcohol; 2015 Dec; 49(8):795-802. PubMed ID: 26095589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PDE10A inhibitors: novel therapeutic drugs for schizophrenia.
    Kehler J; Nielsen J
    Curr Pharm Des; 2011; 17(2):137-50. PubMed ID: 21355834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal structure of the GAF-B domain from human phosphodiesterase 10A complexed with its ligand, cAMP.
    Handa N; Mizohata E; Kishishita S; Toyama M; Morita S; Uchikubo-Kamo T; Akasaka R; Omori K; Kotera J; Terada T; Shirouzu M; Yokoyama S
    J Biol Chem; 2008 Jul; 283(28):19657-64. PubMed ID: 18477562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenylate control in cAMP signaling: implications for adaptation in signalosomes.
    Tulsian NK; Ghode A; Anand GS
    Biochem J; 2020 Aug; 477(16):2981-2998. PubMed ID: 32722762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human Mpv17-like protein with a mitigating effect on mtDNA damage is involved in cAMP/PKA signaling in the mitochondrial matrix.
    Iida R; Ueki M; Yasuda T
    Biochim Biophys Acta Mol Cell Res; 2020 Oct; 1867(10):118792. PubMed ID: 32621840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.